# Atea Pharmaceuticals, Inc. (AVIR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AVIR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -78.37M | $ -83.48M | $ 424.0K | $ 204.16M |
| 2025 | $ 0 | $ -162.14M | $ -135.19M | $ 843.0K | $ 275.43M |
| 2024 | $ 0 | $ -176.99M | $ -142.42M | $ 1.64M | $ 438.87M |
| 2023 | $ 0 | $ -147.00M | $ -92.33M | $ 2.40M | $ 555.19M |
| 2022 | $ 0 | $ -129.48M | $ -137.32M | $ 3.12M | $ 640.57M |
| 2021 | $ 417.65M | $ 144.05M | $ -103.42M | $ 197.0K | $ 710.08M |
| 2020 | $ 61.96M | $ -13.95M | $ 377.99M | $ 0 | $ 547.80M |
| 2019 | $ 0 | $ -18.11M | $ -16.54M | $ 0 | $ 19.54M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 8.13 |

## Other views

- [Metrics](https://sponda.capital/en/AVIR.md)
- [Charts](https://sponda.capital/en/AVIR/charts.md)
- [Compare](https://sponda.capital/en/AVIR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.